Implementation of a national lenalidomide pregnancy prevention programme – Pathfinder Risk Management Platform by NHS England, NHS Scotland, NHS Wales and NHS Northern Ireland. – Webinar Sept 2022

Implementation of a national lenalidomide pregnancy prevention programme – Pathfinder Risk Management Platform by NHS England, NHS Scotland, NHS Wales and NHS Northern Ireland.

Webinar recording available to all PAID and FREE members now on the BOPA website!

Click here to view the video 

 

Latest News

By BOPA Committee on behalf of UK SACT board on 23rd May 2025

UK SACT Board publication: Guidance on the contents of a SACT protocol

  Dear Colleague,   Please find a link to the updated publication, “Guidance for the Content of SACT Protocol,” available here: https://www.uksactboard.org/publications.   This document has been developed to support…

Read article
By BOPA Executive Committee on 21st May 2025

Vision and Common Purpose for UK Pharmacy Professional Leadership – UKPPL Board and BOPA

BOPA is an Ex-Officio Member (Specialist Pharmacy Group) of the UKPPL Board with our Chair, Joseph Williams, representing BOPA members and all Cancer Pharmacy Professionals.  Through the Board’s work, closer…

Read article
By BOPA Executive Committee on 14th May 2025

BOPA Fellowship Nominations are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2025.  There is a clear nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Committee on 13th May 2025

#BOPA2025 at ICC Belfast – Draft Agenda now available

The 28th British Oncology Pharmacy Association (BOPA) Annual Conference, 3-5 October 2025, ICC Belfast The Draft Agenda is available to view here: https://www.bopa.org.uk/resources/the-28th-bopa-annual-conference-2025-draft-agenda/ The conference will include an exciting variety…

Read article